Publications for all Oxford Principal Investigators within the CAMS Oxford Institute are included here, please use the search functions for publications related to specific Principal Investigators.
Concerted deletions eliminate a neutralizing supersite in SARS-CoV-2 BA.2.87.1 spike.
Duyvesteyn HME. et al, (2024), Structure (London, England : 1993), 32, 1594 - 1602.e6
Immunogenicity of Abdala COVID-19 vaccine in Vietnamese people after primary and booster vaccinations: A prospective observational study in Vietnam
Thanh TT. et al, (2024), International Journal of Infectious Diseases, 147, 107173 - 107173
Oligomerization-driven avidity correlates with SARS-CoV-2 cellular binding and inhibition
(2024), Proceedings of the National Academy of Sciences, 121
A structure-function analysis shows SARS-CoV-2 BA.2.86 balances antibody escape and ACE2 affinity
Liu C. et al, (2024), Cell Reports Medicine, 5, 101553 - 101553
Emerging variants develop total escape from potent monoclonal antibodies induced by BA.4/5 infection.
Liu C. et al, (2024), Nature communications, 15
The SARS-CoV-2 neutralizing antibody response to SD1 and its evasion by BA.2.86.
Zhou D. et al, (2024), Nature communications, 15
Dengue and Zika Virus Cross-Reactive Human Monoclonal Antibodies Protect against Spondweni Virus Infection and Pathogenesis in Mice.
Salazar V. et al, (2019), Cell Rep, 26, 1585 - 1597.e4
The immune response against flaviviruses.
Slon Campos JL. et al, (2018), Nat Immunol, 19, 1189 - 1198
Rational Zika vaccine design via the modulation of antigen membrane anchors in chimpanzee adenoviral vectors
López-Camacho C. et al, (2018), Nature Communications, 9
Which Dengue Vaccine Approach Is the Most Promising, and Should We Be Concerned about Enhanced Disease after Vaccination? The Challenges of a Dengue Vaccine.
Screaton G. and Mongkolsapaya J., (2018), Cold Spring Harb Perspect Biol, 10
Evolution of neurovirulent Zika virus.
Screaton G. and Mongkolsapaya J., (2017), Science (New York, N.Y.), 358, 863 - 864
Germline bias dictates cross-serotype reactivity in a common dengue-virus-specific CD8+ T cell response
Culshaw A. et al, (2017), Nature Immunology, 18, 1228 - 1237
Human antibodies to the dengue virus E-dimer epitope have therapeutic activity against Zika virus infection.
Fernandez E. et al, (2017), Nature immunology, 18, 1261 - 1269
The immunopathology of dengue and Zika virus infections.
Culshaw A. et al, (2017), Current opinion in immunology, 48, 1 - 6
Covalently linked dengue virus envelope glycoprotein dimers reduce exposure of the immunodominant fusion loop epitope.
Rouvinski A. et al, (2017), Nature communications, 8, 15411 - 15411
Dengue virus sero-cross-reactivity drives antibody-dependent enhancement of infection with zika virus.
Dejnirattisai W. et al, (2016), Nature immunology, 17, 1102 - 1108
Structural basis of potent Zika-dengue virus antibody cross-neutralization.
Barba-Spaeth G. et al, (2016), Nature, 536, 48 - 53